Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints
- PMID: 12454868
- DOI: 10.1053/gast.2002.37288
Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints
Comment on
-
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.Gastroenterology. 2002 Dec;123(6):1831-8. doi: 10.1053/gast.2002.37058. Gastroenterology. 2002. PMID: 12454840 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
